A study found Gilead Science’s drug remdesivir reduced the risk of death for COVID-19 patients by 62 percent.
Stocks fight for gains as coronavirus treatment shows promise
Leave a reply
- Comment
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Foreaders 